Advertisement
Screener

Neurogene Inc. (NGNE) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Neurogene Inc. Cash Flow Breakdown

Cash flow breakdown shows where Neurogene Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $77.17M went out.
  • Fiscal year ended 2025-12-31: from investing, $14.00M came in.
  • Fiscal year ended 2025-12-31: from financing, $30.43M came in.
  • Fiscal year ended 2025-12-31: change in cash, $32.74M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$77.17M$14.00M$30.38M-$32.74M
2024-12-31-$70.60M-$125.26M$0.00$184.07M*-$11.79M
2023-12-31-$51.42M$25.64M$92.34M$66.70M
2022-12-31-$52.82M-$2.23M$0.00$66.53M*$11.48M
2021-12-31-$47.56M-$3.26M$411.00K-$50.09M
2020-12-31-$24.57M-$2.22M$71.67M$5.46M*$50.34M
2019-12-31-$15.39M-$688.00K$81.04M$1.19M*$66.17M
2018-12-31-$31.58M$55.95M$602.00K$24.90M
2017-12-31-$44.72M$64.01M$438.00K$19.73M
2016-12-31-$30.23M-$48.06M$75.37M-$4.26M*-$7.22M
2015-12-31-$20.27M-$47.53M$98.04M-$5.09M*$24.62M
2014-12-31-$17.49M-$23.57M-$2.61M$53.13M-$5.24M*$3.90M
2013-12-31-$7.82M-$2.64M$2.50M$17.08M*$9.01M
2012-12-31-$7.23M-$6.45K-$7.24M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$23.76M*$6.10M*$22.00K*$5.96M*
2026-03-31-$26.12M$46.24M$201.00K$20.32M
2025-12-31-$17.43M*$29.61M*$20.58M*
2025-09-30-$19.51M*$21.99M*$9.80M*
2025-06-30-$19.46M*$7.45M*$68.00K*
2025-03-31-$20.77M-$45.05M$19.00K-$65.81M
2024-12-31-$17.50M*-$102.62M*$0.00*$190.06M*
2024-09-30-$15.56M*-$28.97M*$143.00K*
2024-06-30-$15.89M*-$23.61M*$415.00K*
2024-03-31-$21.65M$29.93M$629.00K-$7.15M*$1.76M
2023-12-31-$16.97M*$25.83M*$1.00K*$94.30M*
2023-09-30-$11.57M*-$82.00K*$35.00K*-$1.87M*
2023-06-30-$9.33M*-$82.00K*$20.00K*
2023-03-31-$13.55M-$29.00K$112.00K-$13.48M
2022-12-31-$18.15M*$65.37M*-$61.00K*$66.45M*
2022-09-30-$9.29M*-$27.85M*$0.00*
2022-06-30-$11.29M*-$39.30M*$0.00*
2022-03-31-$14.09M-$452.00K$134.00K-$14.41M
2021-12-31-$12.17M*-$396.00K*$3.00K*
2021-09-30-$8.76M*-$587.00K*$32.00K*
2021-06-30-$13.28M*-$1.19M*$94.00K*
2021-03-31-$13.36M-$1.09M$282.00K-$14.16M
2020-12-31-$9.23M*-$653.00K*$0.00*$1.29M*
2020-09-30-$112.00K*-$487.00K*$881.00K*$71.28M*
2020-06-30-$8.79M*-$972.00K*$303.00K*
2020-03-31-$6.44M-$107.00K$3.39M-$3.17M
2019-12-31-$4.64M*-$782.00K*$1.51M*$80.69M*
2019-09-30-$6.53M*
2019-06-30-$1.47M*
2019-03-31-$2.76M-$2.76M
2018-12-31-$9.78M*$0.00*$0.00*
2018-09-30-$15.39M*$3.02M*$0.00*
2018-06-30$9.18M*$22.97M*$399.00K*
2018-03-31-$15.59M$29.96M$203.00K$14.58M
2017-12-31-$11.61M*$16.48M*$58.00K*$4.93M*
2017-09-30-$11.53M*$31.48M*$3.00K*$19.96M*
2017-06-30-$10.30M*$16.16M*$6.23M*
2017-03-31-$11.28M-$108.00K-$11.38M
2016-12-31-$9.00M*-$44.70M*$0.00*-$53.92M*
2016-09-30-$7.44M*-$52.00K*$436.00K*$70.84M*$63.76M*
2016-06-30-$7.92M*-$5.30M*-$13.22M*
2016-03-31-$5.87M$2.00M-$3.83M
2015-12-31-$3.96M*-$65.68M*$0.00*-$69.85M*
2015-09-30-$4.61M*$6.06M*$1.02M*$92.05M*$94.46M*
2015-06-30-$5.40M*$6.03M*$24.00K*$633.00K*
2015-03-31-$6.30M$6.06M$72.00K-$623.00K
2014-12-31-$6.69M*$6.05M*$0.00*$0.00*-$963.00K*
2014-09-30-$4.18M*$2.21M*$0.00*$0.00*-$2.03M*
2014-06-30-$2.81M-$31.83M$0.00*$0.00*-$35.02M
2014-03-31-$3.80M-$4.00K-$2.60M$48.32M*$41.91M
2013-12-31-$3.74M*-$2.81M*$1.81M*-$4.86M*
2013-09-30-$1.74M*$26.45K*-$1.72M*
2013-06-30-$1.44M$101.82K-$1.43M
2013-03-31-$896.62K$46.11K$17.87M*$17.02M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76